Eco R1 Capital, LLC Apellis Pharmaceuticals, Inc. Transaction History
Eco R1 Capital, LLC
- $3.51 Billion
- Q1 2024
A detailed history of Eco R1 Capital, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 11,357,425 shares of APLS stock, worth $436 Million. This represents 19.04% of its overall portfolio holdings.
Number of Shares
11,357,425
Previous 11,173,068
1.65%
Holding current value
$436 Million
Previous $669 Million
0.18%
% of portfolio
19.04%
Previous 19.28%
Shares
9 transactions
Others Institutions Holding APLS
# of Institutions
337Shares Held
111MCall Options Held
1.26MPut Options Held
1.14M-
Wellington Management Group LLP Boston, MA15.1MShares$578 Million0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$426 Million7.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$365 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$211 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.61MShares$177 Million0.17% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.21B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...